MERK: PT Merck Tbk - Summary | Jitta

PT Merck Tbk

IDN:MERK

Price
Rp4,200.00
Loss Chance
41.9%
6.20JITTA SCORE
41.96%Under Jitta Line
Jitta Ranking
5 / 855
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (72)
Recent Business Performance (99)
Financial Strength (92)
Return to Shareholders (51)
Competitive Advantage (69)
Jitta Signs
Revenue and EarningConsistent Growth in the past 5 years
Recent Business PerformanceEarning Growth Last Year
Operating MarginConsistent
Debt LevelLow Long Term Debt
Interest Coverage RatioVery Good
Cash Conversion CycleMore than 120 days
Key Stats
Jitta Score
Jitta Line
6.20
41.96%
4.68
45.84%
4.29
428.89%
Pharmaceuticals
4.57
50.64%
3.68
133.17%
6.76
9.02%
COMPANY DESCRIPTION
PT Merck Tbk engages in the manufacture and sale of pharmaceutical products in Indonesia and internationally. The company operates through Biopharma, Consumer Health, and Others segments. It offers health care products in the areas of cardiovascular, metabolic, oncology, endocrinology, fertility, and neurodegenerative diseases, as well as general medicines. The company also engages in research an, development, production, and distribution of pharmaceutical and biological prescription medicines to treat colorectal cancer, head and neck cancer, multiple sclerosis, infertility, growth hormone disorders, and diabetes, as well as thyroid disorders, such as hypothyroidism. In addition, it is involved in the office/property leasing and management activities. The company was formerly known as PT Merck Indonesia Tbk and changed its name to PT Merck Tbk in June 2002. The company was founded in 1970 and is based in Jakarta Timur, Indonesia. PT Merck Tbk operates as a subsidiary of Merck Holding GmbH.